PURPOSE: Evidence has suggested a clinically meaningful relationship between self-reported quality of life (QOL) of a patient with cancer at the time of receiving a cancer diagnosis and overall survival (OS). This study evaluated the prognostic value of QOL assessments with regard to OS in a large cohort of patients with lung cancer. PATIENTS AND METHODS: A total of 2,442 patients with non-small-cell lung cancer were observed between 1997 and 2007 and completed a single-item measure of overall QOL within the first 6 months of receiving a lung cancer diagnosis; these were dichotomized using an a priori definition of a clinically deficient score (CDS; ≤ 50 v > 50). Kaplan-Meier estimates and Cox models were used to evaluate the prognostic importance of QOL on OS alone and in the presence of covariates. Logistic regression modeling was used to identify which clinical and patient characteristics were related to a clinically meaningful deficit in QOL. RESULTS: QOL deficits at time of lung cancer diagnosis were significantly associated with OS (hazard ratio [HR], 1.55; P < .001), as were performance status, older age, smoking history, male sex, treatment factors, and stage of disease. The median survival for patients with CDS QOL was 1.6 years versus 5.6 years for patients with non-CDS QOL. After controlling for all these covariates, the indication of a clinically deficient baseline QOL still contributed significantly to the prediction of patient survival (HR, 0.67; P < .001). CONCLUSION: Overall QOL measured by a simple single item at the time of lung cancer diagnosis is a significant and independent prognostic factor for survival in patients with lung cancer.
PURPOSE: Evidence has suggested a clinically meaningful relationship between self-reported quality of life (QOL) of a patient with cancer at the time of receiving a cancer diagnosis and overall survival (OS). This study evaluated the prognostic value of QOL assessments with regard to OS in a large cohort of patients with lung cancer. PATIENTS AND METHODS: A total of 2,442 patients with non-small-cell lung cancer were observed between 1997 and 2007 and completed a single-item measure of overall QOL within the first 6 months of receiving a lung cancer diagnosis; these were dichotomized using an a priori definition of a clinically deficient score (CDS; ≤ 50 v > 50). Kaplan-Meier estimates and Cox models were used to evaluate the prognostic importance of QOL on OS alone and in the presence of covariates. Logistic regression modeling was used to identify which clinical and patient characteristics were related to a clinically meaningful deficit in QOL. RESULTS: QOL deficits at time of lung cancer diagnosis were significantly associated with OS (hazard ratio [HR], 1.55; P < .001), as were performance status, older age, smoking history, male sex, treatment factors, and stage of disease. The median survival for patients with CDS QOL was 1.6 years versus 5.6 years for patients with non-CDS QOL. After controlling for all these covariates, the indication of a clinically deficient baseline QOL still contributed significantly to the prediction of patient survival (HR, 0.67; P < .001). CONCLUSION: Overall QOL measured by a simple single item at the time of lung cancer diagnosis is a significant and independent prognostic factor for survival in patients with lung cancer.
Authors: D M Finkelstein; B R Cassileth; P D Bonomi; J C Ruckdeschel; E Z Ezdinli; J M Wolter Journal: Am J Clin Oncol Date: 1988-12 Impact factor: 2.339
Authors: Antonio L Visbal; Brent A Williams; Francis C Nichols; Randolph S Marks; James R Jett; Marie-Christine Aubry; Eric S Edell; Jason A Wampfler; Julian R Molina; Ping Yang Journal: Ann Thorac Surg Date: 2004-07 Impact factor: 4.330
Authors: O P Geerse; D Brandenbarg; H A M Kerstjens; A J Berendsen; S F A Duijts; H Burger; G A Holtman; J E H M Hoekstra-Weebers; T J N Hiltermann Journal: Lung Cancer Date: 2019-02-10 Impact factor: 5.705
Authors: Juliane Bingener; Jeff A Sloan; Drew K Seisler; Andrea L McConico; Pamela E Skaran; David R Farley; Mark J Truty Journal: J Gastrointest Surg Date: 2015-03-18 Impact factor: 3.452
Authors: William A Wood; Jennifer Le-Rademacher; Karen L Syrjala; Heather Jim; Paul B Jacobsen; Jennifer M Knight; Muneer H Abidi; John R Wingard; Navneet S Majhail; Nancy L Geller; J Douglas Rizzo; Mingwei Fei; Juan Wu; Mary M Horowitz; Stephanie J Lee Journal: Cancer Date: 2015-10-06 Impact factor: 6.860
Authors: Donald R Sullivan; Karen B Eden; Nathan F Dieckmann; Sara E Golden; Kelly C Vranas; Shannon M Nugent; Christopher G Slatore Journal: Lung Cancer Date: 2019-03-09 Impact factor: 5.705
Authors: Juliane Bingener; Jeff A Sloan; Paul J Novotny; Barbara A Pockaj; Heidi Nelson Journal: J Gastrointest Surg Date: 2014-08-05 Impact factor: 3.452
Authors: Rebecca Selove; Maya Foster; Debra Wujcik; Maureen Sanderson; Pamela C Hull; David Shen-Miller; Steven Wolff; Debra Friedman Journal: Support Care Cancer Date: 2016-11-08 Impact factor: 3.603
Authors: Bradley J Barney; Xin Shelley Wang; Charles Lu; Zhongxing Liao; Valen E Johnson; Charles S Cleeland; Tito R Mendoza Journal: Qual Life Res Date: 2013-01-31 Impact factor: 4.147